Highlights and Quick Summary
- Current Part of Debt for the quarter ending June 30, 2023 was $455 Million (a -52.12% decrease compared to previous quarter)
- Year-over-year quarterly Current Part of Debt increased by 1585.93%
- Annual Current Part of Debt for 2022 was $957 Million (a 2929.43% increase from previous year)
- Annual Current Part of Debt for 2021 was $31.6 Million (a -18.97% decrease from previous year)
- Annual Current Part of Debt for 2020 was $39 Million (a 202.33% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Current Part of Debt of Emergent Biosolutions Inc.
Most recent Current Part of Debtof EBS including historical data for past 10 years.Interactive Chart of Current Part of Debt of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Current Part of Debt for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $455.2 | $950.7 | – | – | – |
| 2022 | $957.3 | $27.0 | $31.6 | $31.6 | $957.3 |
| 2021 | $31.6 | $31.6 | $28.8 | $26.0 | $31.6 |
| 2020 | $39.0 | $30.9 | $34.0 | $26.3 | $39.0 |
| 2019 | – | $12.9 | $10.1 | $10.1 | $12.9 |
| 2018 | – | – | – | $10.1 | $10.1 |
| 2016 | – | – | – | – | $20.0 |
| 2014 | – | – | – | $2.49 | – |
| 2013 | – | $4.47 | $4.47 | $4.47 | – |
| 2012 | $4.47 | $4.15 | – | – | $4.47 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic